Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery-Reference-Cited by-同舟云学术

Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery

Published:2023 Issue:12 Volume:11 Page:4094-4131
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Nozhat Zahra¹^ORCID,Heydarzadeh Shabnam²,Shahriari-Khalaji Mina³^ORCID,Wang Shibo¹^ORCID,Iqbal M. Zubair¹^ORCID,Kong Xiangdong¹^ORCID

Affiliation:

1. Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China

2. Cellular and Molecular Endocrine Research Center, Research Institute of Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3. State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai, 201620, China

Abstract

Biomaterial-based drug delivery systems (DDSs) for GBM drug delivery are classified as organic, inorganic and cell-based nanoparticles.

Funder

Zhejiang Sci-Tech University

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/BM/D2BM01996E

Reference234 articles.